Skip to main content
Top
Published in: Journal of General Internal Medicine 7/2013

01-07-2013 | Letters

Community-Acquired Pneumonia and Proton Pump Inhibitors

Author: David C. Norris, MD

Published in: Journal of General Internal Medicine | Issue 7/2013

Login to get access

Excerpt

To the Editors:—I thank Drs. Jena, Sun and Goldman for applying an interesting falsification method to investigate the observed association between PPI use and incident community-acquired pneumonia.1 The authors advocate their method as “an intuitive approach to assessing the likelihood of confounding in observational studies” and as perhaps useful “for validating the causal plausibility of observational studies more generally.” I wish to recast the authors’ analysis in a form better aligned with modern concepts of causal inference, clarifying the underlying intuition and suggesting a suitable role for their method in the process of model-based data analysis. …
Literature
1.
go back to reference Jena AB, Sun E, Goldman DP. Confounding in the association of proton pump inhibitor use with risk of community-acquired pneumonia. J Gen Intern Med. 2013;28:223–30.PubMedCrossRef Jena AB, Sun E, Goldman DP. Confounding in the association of proton pump inhibitor use with risk of community-acquired pneumonia. J Gen Intern Med. 2013;28:223–30.PubMedCrossRef
2.
go back to reference Howards PP, Schisterman EF, Poole C, Kaufman JS, Weinberg CR. ‘Toward a clearer definition of confounding’ revisited with directed acyclic graphs. Am J Epidemiol. 2012;176:506–11.PubMedCrossRef Howards PP, Schisterman EF, Poole C, Kaufman JS, Weinberg CR. ‘Toward a clearer definition of confounding’ revisited with directed acyclic graphs. Am J Epidemiol. 2012;176:506–11.PubMedCrossRef
3.
go back to reference Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology. 1999;10:37–48.PubMedCrossRef Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology. 1999;10:37–48.PubMedCrossRef
Metadata
Title
Community-Acquired Pneumonia and Proton Pump Inhibitors
Author
David C. Norris, MD
Publication date
01-07-2013
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 7/2013
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-013-2431-3

Other articles of this Issue 7/2013

Journal of General Internal Medicine 7/2013 Go to the issue

From the Editors' Desk

Getting Back to Basics

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine